New insights on SOM230, a universal somatostatin receptor ligand

J Endocrinol Invest. 2003;26(8 Suppl):14-6.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Comparative Study

MeSH terms

  • Acromegaly / drug therapy*
  • Acromegaly / metabolism
  • Dose-Response Relationship, Drug
  • Drug Evaluation
  • Drug Tolerance
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / therapeutic use*
  • Human Growth Hormone / drug effects*
  • Human Growth Hormone / metabolism
  • Nausea / etiology
  • Octreotide / adverse effects
  • Octreotide / therapeutic use
  • Receptors, Somatostatin / classification
  • Receptors, Somatostatin / drug effects
  • Reference Values
  • Somatostatin / adverse effects
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use*
  • Vomiting / etiology

Substances

  • Drugs, Investigational
  • Receptors, Somatostatin
  • Human Growth Hormone
  • Somatostatin
  • pasireotide
  • Octreotide